GlobeNewswire Clinical StudiesOriginal article
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
Data ReadoutOPGx-BEST1Neutral
AI Analysis
Summary
Opus Genetics announced an update to its BEST1 program and provided a detailed timeline for OPGx-BEST1 results. The article contains limited details about the specific outcome, timing, or clinical data.
Clinical Trial Data
Importance:4/10
Sentiment:
0.00
BEST1OPGx-BEST1program updateclinical trial
Read the original article
Published by GlobeNewswire Clinical Studies on July 9, 2026 11:00 AM
